Project Number 1R56AG053267-01 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for DIAN-TU: NEXT GENERATION PREVENTION TRIAL Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator Bateman, Randall Principal Investigator First Name Randall Principal Investigator Last Name Bateman Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-302: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $3,231,879 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
